Works Cited

1. National Institute of Child Health and Human Development. Autism Spectrum Disorder (ASD). Available at https://www.nichd.nih.gov/health/topics/autism. Last accessed December 12, 2019.

2. Gerlach EK. Autism Treatment Guide. 3rd ed. Arlington, TX: Future Horizons, Inc.; 2003.

3. Centers for Disease Control and Prevention. Data and Statistics on Autism Spectrum Disorder. Available at https://www.cdc.gov/ncbddd/autism/data.html. Last accessed December 12, 2019.

4. Baron-Cohen S, Bolton P. Autism: The Facts. New York, NY: Oxford University Press; 1993.

5. Kaneshiro NK, Zieve D. Autism. Available at https://medlineplus.gov/ency/article/001526.htm. Last accessed December 12, 2019.

6. Centers for Disease Control and Prevention. Mental health in the United States: parental report of diagnosed autism in children aged 4–17 years—United States, 2003–2004. MMWR. 2006;55(17):481-486.

7. Remedy Health Media. Autism Overview. Available at http://www.healthcommunities.com/autism/children/overview-of-autism.shtml. Last accessed December 12, 2019.

8. Cohen S. Targeting Autism: What We Know, Don't Know, and Can Do to Help Young Children with Autism Spectrum Disorders. 3rd ed. Berkeley, CA: University of California Press, Ltd.; 2006.

9. Grandin T, Scariano MM. Emergence: Labeled Autistic. 1st ed. New York, NY: Warner Books Edition; 1996.

10. Hutton J. Does rubella cause autism: a 2015 reappraisal? Front Hum Neurosci. 2016;10:25.

11. Yamashita Y, Fujimoto C, Nakajima E, Isagai T, Matsuishi T. Possible association between congenital cytomegalovirus infection and autistic disorder. J Autism Dev Disord. 2003;33(4):455-459.

12. Weiss LA. Autism genetics: emerging data from genome-wide copy-number and single nucleotide polymorphism scans. Expert Rev Mol Diagn.2009;9(8):795-803.

13. Geier DA, Geier MR. Early downward trends in neurodevelopmental disorders following removal of thimerosal-containing vaccines. J Am Phys Surg. 2006;11(1):8-13.

14. Orenstein WA, Paulson JA, Brady MT, Cooper LZ, Seib K. Global vaccination recommendations and thimerosal. Pediatrics. 2013;131(1):149-151.

15. Geier MR, Geier DA. Neurodevelopmental disorders after thimerosal-containing vaccines: a brief communication. Exp Biol Med. 2003;228(6):660-664.

16. Medscape Medical News. Autism "Epidemic?" A Newsmaker Interview with Morton Ann Gernsbacher, PhD, and Craig J. Newschaffer, PhD. Available at https://www.medscape.com/viewarticle/508429. Last accessed December 12, 2019.

17. Rice C, Nicholas J, Baio J, et al. Changes in autism spectrum disorder prevalence in 4 areas of the United States. Dis Health J. 2010;3(3):186-201.

18. American Academy of Pediatrics, United States Public Health Service. Joint statement of the American Academy of Pediatrics (AAP) and the United States Public Health Service (USPHS). Pediatrics. 1999;104(3 Pt 1):568-569.

19. National Academy of Sciences. Link Between Neurodevelopmental Disorders and Thimerosal Remains Unclear. Available at http://www8.nationalacademies.org/onpinews/newsitem.aspx?RecordID=10208. Last accessed December 12, 2019.

20. National Academy of Sciences. MMR Vaccine and Thimerosal-Containing Vaccines Are Not Associated with Autism, IOM Report Says. Available at http://www8.nationalacademies.org/onpinews/newsitem.aspx?RecordID=10997. Last accessed December 12, 2019.

21. Institute of Medicine Immunization Safety Review Committee. Immunization Safety Review: Vaccines and Autism. Washington, DC: National Academies Press; 2004.

22. Schechter R, Grether JK. Continuing increases in autism reported to California's development services system: mercury in retrograde. Arch Gen Psychiatry. 2008;65(1):19-24.

23. Centers for Disease Control and Prevention. Vaccines Do Not Cause Autism. Available at https://www.cdc.gov/vaccinesafety/concerns/autism.html. Last accessed December 12, 2019.

24. Gillberg C, Coleman M. The Biology of the Autistic Syndromes. 3rd ed. London: Mac Keith Press; 2000.

25. Chakrabarti S, Fombonne E. Pervasive developmental disorders in preschool children. JAMA. 2001;285(24):3093-3099.

26. Chudley AE, Gutierrez E, Jocelyn LJ, Chodirker BN. Outcomes of genetic evaluation in children with pervasive developmental disorder. J Dev Behav Pediatr. 1998;19(5):321-325.

27. Muhle R, Trentacoste SV, Rapin I. The genetics of autism. Pediatrics. 2004;113(5):e472-e486.

28. Sadakata T, Washida M, Iwayama Y, et al. Autistic-like phenotypes in CADPS2-knockout mice and aberrant CADPS2 splicing in autistic patients. J Clin Invest. 2007;117(4):931-943.

29. Rosenberg RE, Law K, Yenokyan G, McGready J, Kaufmann WE, Law PA. Characteristics and concordance of autism spectrum disorders among 277 twin pairs. Arch Pediatr Adolesc Med. 2009;163(10):907-914.

30. Steinman L. Elaborate interactions between the immune and nervous systems. Nat Immunol. 2004;5(6):575-581.

31. Volkmar F, Siegel M, Woodbury-SmithM, et al. Practice parameter for the assessment and treatment of children and adolescents with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry. 2014;53(2):237-257.

32. American Academy of Neurology. Screening and Diagnosis of Autism: Guideline for Clinicians. Available at https://www.aan.com/Guidelines/home/GuidelineDetail/33. Last accessed December 12, 2019.

33. Richler E, Reichert JG, Buxbaum JD, McInnes LA. Autism and ultraconserved non-coding sequence on chromosome 7q. Psychiatr Genet. 2006;16(1):19-23.

34. Curran LK, Newschaffer CJ, Lee LC, Crawford SO, Johnston MV, Zimmerman AW. Behaviors associated with fever in children with autism spectrum disorders. Pediatrics. 2007;120(6):e1386-e1392.

35. Zhao X, Leotta A, Kustanovich V, et al. A unified genetic theory for sporadic and inherited autism. PNAS. 2007;104(31):12831-12836.

36. Tuberous Sclerosis Alliance. TSC and Autism Spectrum Disorders. Available at https://www.tsalliance.org/about-tsc/signs-and-symptoms-of-tsc/brain-and-neurological-function/tsc-and-autism-spectrum-disorders. Last accessed December 12, 2019.

37. Tuberous Sclerosis Alliance. What is TSC? Available at https://www.tsalliance.org/about-tsc/what-is-tsc/. Last accessed December 12, 2019.

38. The National Fragile X Foundation. Fragile X and Autism. Available at https://fragilex.org/understanding-fragile-x/fragile-x-syndrome/autism/. Last accessed December 12, 2019.

39. Palmer CA. Mobius Syndrome. Available at https://emedicine.medscape.com/article/1180822-overview. Last accessed December 12, 2019.

40. Larsson HJ, Eaton WW, Madsen KM, et al. Risk factors for autism: perinatal factors, parental psychiatric history, and socioeconomic status. Am J Epidemiol. 2005;161(10):916-925.

41. Kolevzon A, Gross R, Reichenberg A. Prenatal and perinatal risk factors for autism. Arch Pediatr Adolesc Med. 2007;161:326-333.

42. Durkin MS, Maenner MJ, Newschaffer CJ, et al. Advanced parental age and the risk of autism spectrum disorder. Am J Epidemiol. 2008;168(11):1268-1276.

43. Glasson EJ, Bower C, Petterson B, de Klerk N, Chaney G, Hallmayer JF. Perinatal factors and the development of autism: a population study. Arch Gen Psychiatry. 2004;61(6):618-627.

44. Auyeung B, Baron-Cohen S, Ashwin E, Knickmeyer R, Taylor K, Hackett G. Fetal testosterone and autistic traits. Br J Psychol. 2009;199(pt 1):1-22.

45. DeStefano F, Chen RT. Autism and measles-mumps-rubella vaccination: controversy laid to rest? CNS Drugs. 2001;15(11):831-837.

46. Miller E. Measles-mumps-rubella vaccine and the development of autism. Semin Pediatr Infect Dis. 2003;14(3):199-206.

47. Lintas C, Altieri L, Lombardi F, Sacco R, Persico AM. Association of autism with polyomavirus infection in postmortem brains.J Neurovirol. 2010;16(2):141-149.

48. Nordin J, Anderson R, Anderson R, et al. Immunizations. Bloomington, MN: Institute for Clinical Systems Improvement; 2012.

49. Courchesne E, Carper R, Akshoomoff N. Evidence of brain overgrowth in the first year of life in autism. JAMA. 2003;290(3):337-344.

50. Hazlett HC, Poe M, Gerig G, et al. Magnetic resonance imaging and head circumference study of brain size in autism: birth through age 2 years. Arch Gen Psychiatry.2005;62(12):1366-1376.

51. Hrdlicka M. EEG abnormalities, epilepsy and regression in autism: a review. Neuro Endocrinol Lett. 2008;29(4):405-409.

52. Rippon G, Brock J, Brown C, Boucher J. Disordered connectivity in the autistic brain: challenges for the "new psychophysiology." Int J Psychophysiol. 2007;63(2):164-172.

53. Di Martino A, Shehzad Z, Kelly C, et al. Relationship between cingulo-insular functional connectivity and autistic traits in neurotypical adults. Am J Psychiatry. 2009;166(8):891-899.

54. Janusonis S. Origin of the blood hyperserotonemia of autism. Theoret Biol Med Modelling. 2008;5:10.

55. Anderson BM, Schnetz-Boutaud NC, Barlett J, et al. Examination of association of genes in the serotonin system to autism. Neurogenetics. 2009;10(3):209-216.

56. Connors SL, Matteson KJ, Sega GA, Lozzio CB, Carroll RC, Zimmerman AW. Plasma serotonin in autism. Pediatr Neurol.2006;35(3):182-186.

57. Piven J, Tsai GC, Nehme E, Coyle JT, Chase GA, Folstein SE. Platelet serotonin, a possible marker for familial autism. J Autism Dev Disord. 1991;21(1):51-59.

58. Betancur C. Corbex M, Spielewoy C, et al. Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder. Mol Psychiatry. 2002;7(1):67-71.

59. Huang CH, Santangelo SL. Ausitm and serotonin transporter gene polymorphisms: a systematic review and meta-analysis.Am J Med Genet B Neuropsychiatr Genet. 2008;147B(6):903-913.

60. Yasuhara A. Correlation between EEG abnormalities and symptoms of autism spectrum disorder (ASD). Brain Dev. 2010;32(10):791-798.

61. Sundaram SK, Kumar A, Makki MI, Behen ME, Chugani HT, Chugani DC. Diffusion tensor imaging of frontal lobe in autism spectrum disorder. Cereb Cortex. 2008;18(11):2659-2665.

62. World Health Organization. International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10). 2nd ed. Geneva; World Health Organization; 2004.

63. American Academy of Family Physicians. AAP Releases Guidelines on Identification of Children with Autism Spectrum Disorders. Available at https://www.aafp.org/afp/2008/1201/p1301.html. Last accessed December 12, 2019.

64. American Speech-Language-Hearing Association. Selective Mutism. Available at https://www.asha.org/public/speech/disorders/selectivemutism.htm. Last accessed December 12, 2019.

65. American Academy of Child and Adolescent Psychiatry. Attachment Disorders: Facts for Families. Available at https://www.aacap.org/AACAP/Families_and_Youth/Facts_for_Families/FFF-Guide/Attachment-Disorders-085.aspx. Last accessed December 12, 2019.

66. National Institute of Neurological Disorders and Stroke. Pervasive Developmental Disorders Information Page. Available at https://www.ninds.nih.gov/Disorders/All-Disorders/Pervasive-Developmental-Disorders-Information-Page. Last accessed December 12, 2019.

67. National Institute of Neurological Disorders and Stroke. Rett Syndrome Information Page. Available at https://www.ninds.nih.gov/Disorders/All-Disorders/Rett-Syndrome-Information-Page. Last accessed December 12, 2019.

68. National Institute of Neurological Disorders and Stroke. Landau-Kleffner Syndrome Information Page. Available at https://www.ninds.nih.gov/Disorders/All-Disorders/Landau-Kleffner-Syndrome-Information-Page. Last accessed December 12, 2019.

69. Nation K, Penny S. Sensitivity to eye gaze in autism: is it normal? Is it automatic? Is it social. Dev Psychopathol. 2008;20(1):79-97.

70. Senju A, Kikuchi Y, Hasegawa T, Tojo Y, Osanai H. Is anyone looking at me? Direct gaze detection in children with and without autism. Brain Cogn. 2008;67(2):127-139.

71. Rapin I, Dunn M. Update on the language disorders of individuals on the autistic spectrum. Brain Dev. 2003;25(3):166-172.

72. McCann J, Peppe S, Gibbon FE, O'Hare A, Rutherford M. Prosody and its relationship to language in school-aged children with high-functioning autism. Int J Lang Commun Disord. 2007;42(6):682-702.

73. Diehl JJ, Bennetto L, Watson D, Gunlogson C, McDonough J. Resolving ambiguity: a psycholinguistic approach to understanding prosody processing in high-functioning autism. Brain Lang. 2008;106(2):144-152.

74. McCroskery M. Asperger's syndrome: a developmental puzzle. The Reporter. 2000;5(3):13-14.

75. Gerhardt PF. The Current State of Services for Adults with Autism. Available at http://www.afaa-us.org/storage/documents/OAR_NYCA_survey_Current_State_of_Services_for_Adults_with_Autism.pdf. Last accessed December 12, 2019.

76. Wiggins LD, Baio J, Rice C. Examination of the time between first evaluation and first autism spectrum diagnosis in a population-based sample. J Dev Behav Pediatr. 2006;27(2 Suppl):S79-S87.

77. Kogan MD, Vladutiu CJ, Schieve LA, et al. The prevalence of parent-reported autism spectrum disorder among U.S. children. Pediatrics. 2018;142(6).

78. Ozonoff S, Young GS, Carter A, et al. Recurrence risk for autism spectrum disorders: a Baby Siblings Research Consortium study. Pediatrics. 2011;128(3):e488-495.

79. Shulman L. DSM-5 and the New Autism Spectrum Disorder Criteria: What's It All About? Available at http://www.einstein.yu.edu/uploadedfiles/Centers/childrens-evaluation-rehabilitation/eiti-summer-2013.pdf. Last accessed December 12, 2019.

80. King BH, Hollander E, Sikich L, et al. Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. Arch Gen Psychiatry. 2009;66(6):583-590.

81. Williams K, Wheeler DM, Silove N, Hazell P. Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). Cochrane Database Syst Rev. 2010;(8):CD004677.

82. Deonna T, Roulet-Perez E. Early-onset acquired epileptic asphasia (Landau-Kleffner syndrome, LKS) and regressive autistic disorders with epileptic EEG abnormalities: the continuing debate. Brain Dev. 2010;32(9):746-752.

83. Neiman ES, Seyffert M. Acquired Epileptic Aphasia. Available at https://emedicine.medscape.com/article/1176568-overview. Last accessed December 12, 2019.

84. Prater CD, Zylstra RG. Autism: a medical primer. Am Fam Phys. 2002;66(9):1667-1675.

85. Duran MH, Guimaraes CA, Medeiros LL, Guerreiro MM. Landau-Kleffner syndrome: long-term follow-up. Brain Dev. 2009;31(1):58-63.

86. Fombone E. Prevalence of childhood disintegrative disorder. Autism. 2002;6(2):149-157.

87. Homan KJ, Mellon MW, Houlihan D, Katusic MZ. Brief report: childhood disintegrative disorder: a brief examination of eight case studies. J Autism Dev Disord. 2011;41(4):497-504.

88. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.

89. Huerta M, Bishop SL, Duncan A, Hus V, Lord C. Application of DSM-5 criteria for autism spectrum disorder to three samples of children with DSM-IV diagnoses of pervasive developmental disorders. Am J Psychiatry. 2012;169(10):1056-1064.

90. Armstrong D. Gene identified for Rett Syndrome: MECP21. NARRATIVE. 2000;6:17.

91. Finucane B, Abrams L, Cronister A, Archibald AD, Bennett RL, McConkie-Rosell A. Genetic counseling and testing for FMR1 gene mutations: practice guidelines of the national society of genetic counselors. J Genet Couns. 2012;21(6):752-760.

92. Stachnik JM, Nunn-Thompson C. Use of atypical antipsychotics in the treatment of autistic disorder. Ann Pharmacother. 2007;41(4):626-634.

93. Nickels K, Katusic SK, Colligan RC, Weaver AL, Voigt RG, Barbaresi WJ. Stimulant medication treatment of target behaviors in children with autism: a population-based study. J Dev Behav Pediatr. 2008;29(2):75-81.

94. Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, Malhotra AK. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA. 2009;302(16):1765-1773.

95. Malone RP, Waheed A. The role of antipsychotics in the management of behavioural symptoms in children and adolescents with autism. Drugs.2009;69(5):535-548.

96. Swinson RP, Antony MM, Rachman S, Richter MA (eds). Obsessive-Compulsive Disorder Theory, Research, and Treatment. New York, NY: The Guilford Press; 1998.

97. National Institute of Mental Health. Autism Spectrum Disorder. Available at https://www.nimh.nih.gov/health/topics/autism-spectrum-disorders-asd/index.shtml. Last accessed December 12, 2019.

98. LexiComp Online. Available at https://online.lexi.com. Last accessed December 12, 2019.

99. U.S. Food and Drug Administration. FDA Approves the First Drug to Treat Irritability Associated with Autism, Risperdal. Available at https://wayback.archive-it.org/7993/20170113132901/http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108759.htm. Last accessed November 28, 2016.

100. Jesner OS, Aref-Adib M, Coren E. Risperidone for autism spectrum disorder. Cochrane Database Syst Rev. 2007;(1):CD005040.

101. McCracken JT, McGough J, Shah B, et al. Risperidone in children with autism and serious behavioral problems. N Engl J Med. 2002;347:314-321.

102. Malone RP, Cater J, Sheikh RM, Choudhury MS, Delaney MA. Olanzapine versus haloperidol in children with autistic disorder: an open pilot study. J Am Acad Child Adolesc Psychiatry. 2001;40(8):887-894.

103. Barnard L, Young AH, Pearson J, Geddes J, O'Brien G. A systematic review of the use of atypical antipsychotics in autism.J Psychopharmacol. 2002;16(1):93-101.

104. McDougle CJ, Kem DL, Posey DJ. Case series: use of ziprasidone for maladaptive symptoms in youths with autism. J Am Acad Child Adolesc Psychiatry. 2002;41(8):921-927.

105. Posey DJ, Aman MG, McCracken JT, et al. Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures. Biol Psychiatry. 2007;61(4):538-544.

106. National Institutes of Health. The Use of Secretin to Treat Autism. Available at https://www.nichd.nih.gov/newsroom/releases/secretin. Last accessed December 12, 2019.

107. Williams KJ, Wray JJ, Wheeler DM. Intravenous secretin for autism spectrum disorders (ASD). Cochrane Database Syst Rev. 2012;(4):CD003495.

108. Adams JP. Summary: Diet, Nutrition, Medical Treatments. Available at https://www.autism.org/summary-diet-nutrition-medical-treatments. Last accessed December 12, 2019.

109. National Autism Resources. Picture Exchange Communication System (PECS). Available at https://www.nationalautismresources.com/the-picture-exchange-communication-system-pecs. Last accessed December 12, 2019.

110. Nye C, Brice A. Combined vitamin B6-magnesium treatment in autism spectrum disorder. Cochrane Database Syst Rev. 2005;19(4):CD003497.

111. Hjiej H, Doyen C, Couprie C, Kaye K, Contejean Y. Substitutive and dietetic approaches in childhood autistic disorder: Interests and limits. Encephale. 2008;34(5):496-503.

112. Millward C, Ferriter M, Calver S, Connell-Jones G. Gluten- and casein-free diets for autistic spectrum disorder. Cochrane Database Syst Rev. 2008;16(2):CD003498.

113. American College of Allergy, Asthma, and Immunology. Food allergy: a practice parameter. Ann Allergy Asthma Immunol. 2006;96(3 suppl 2):S1-S68.

114. Levy SE, Hyman SL. Novel treatments for autistic spectrum disorders. Ment Retard Dev Disabil Res Rev. 2005;11(2):131-142.

115. Baron-Cohen S. Theory of mind in normal development and autism. Prisme. 2001;34:174-183.

116. Interactive Autism Network (IAN) Community. Social Skills Interventions: Getting to the Core of Autism. Available at https://www.iancommunity.org/cs/what_do_we_know/social_skills_interventions. Last accessed December 12, 2019.

117. Bondy A, Frost L. The picture exchange communication system. Behav Modif. 2001;25(5):725-744.

118. The National Autistic Society. Communicating. Available at https://www.autism.org.uk/about/communication/communicating.aspx. Last accessed December 12, 2019.

119. Schwartz IS, Garfinkle AN, Bauer J. The picture exchange communication system: communicative outcomes for young children with disabilities. Top Early Child Special Education. 1998;18(3):144-159.

120. American Occupational Therapy Association. Supporting Parents of Children With Autism: The Role of Occupational Therapy. Available at https://www.aota.org/about-occupational-therapy/professionals/cy/articles/parents-autism.aspx. Last accessed December 12, 2019.

121. Interactive Autism Network Community. IAN Research Findings: Occupational Therapy. Available at https://www.iancommunity.org/cs/ian_treatment_reports/occupational_therapy. Last accessed December 12, 2019.

122. Lange KW, Hauser J, Reissmann A. Gluten-free and casein-free diets in the therapy of autism. Curr Opin Clin Nutr Metab Care. 2015;18(6):572-575.

123. AutismSpeaks.org. 100 Day Kit for Young Children. Available at https://www.autismspeaks.org/tool-kit/100-day-kit-young-children. Last accessed December 12, 2019.

124. Josefi O, Ryan V. Non-directive play for young children with autism: a case study. Clin Child Psychol Psychiatry. 2004;9(4):533-551.

125. Holmes AS. Early Intervention Can Make a Difference. Available at https://autism-society.org/wp-content/uploads/2014/04/early-intervention.pdf. Last accessed December 12, 2019.

126. Autism Society. Educational Planning. Available at https://www.autism-society.org/living-with-autism/academic-success/educational-planning. Last accessed December 12, 2019.

127. Buckman S, Indiana Resource Center for Autism. Critical Features of Early Intervention: Merging Best Practices. Available at https://www.iidc.indiana.edu/index.php?pageId=442. Last accessed December 12, 2019.

128. British Columbia Ministry of Education: Special Programs Branch. Teaching Students with Autism: A Resource Guide for Schools. Available at https://www2.gov.bc.ca/assets/gov/education/kindergarten-to-grade-12/teach/teaching-tools/inclusive/autism.pdf. Last accessed December 12, 2019.

129. National Institute on Deafness and Other Communication Disorders. Autism Spectrum Disorder: Communication Problems in Children. Available at https://www.nidcd.nih.gov/health/autism-spectrum-disorder-communication-problems-children. Last accessed December 12, 2019.

130. Autism Now. Developmental Relationship-Based Approaches to Educating Children with Autism Spectrum Disorder. Available at https://autismnow.org/articles/developmental-relationship-based-approaches-to-educating-children-with-autism-spectrum-disorder/. Last accessed December 12, 2019.

131. Committee on Educational Interventions for Children with Autism, Lord C, McGee J (eds). Educating Children with Autism. Washington, DC: National Academies Press; 2001.

132. Harris SL, Handleman JS. Age and IQ at intake as predictors of placement for young children with autism: a four-to-six-year follow-up. J Autism Dev Disord. 2000;30(2):137-142.

133. Vicker B, Indiana Resource Center for Autism. Aiding Comprehension of Individuals with Autism Spectrum Disorders during One-on-One Interactions. Available at https://www.iidc.indiana.edu/index.php?pageId=538. Last accessed December 12, 2019.

134. Goldstein H. Communication intervention for children with autism: a review of treatment efficacy. J Autism Dev Disord. 2002;32(5):373-396.

135. Fernandez BA, Roberts W, Chung B, et al. Phenotypic spectrum associated with de novo and inherited deletions and duplications at 16p11.2 in individuals ascertained for diagnosis of autism spectrum disorder. J Med Genet. 2010;47:195-203.

136. Baio J, Wiggins L, Christensen DL, et al. Prevalence of autism spectrum disorder among children aged 8 years—Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2014. MMWR Surveill Summ. 2018;67(6):1-23.

137. Centers for Disease Control and Prevention. Key Findings: The Association Between Assisted Reproductive Technology And Autism Spectrum Disorder. Available at https://www.cdc.gov/ncbddd/autism/features/artandasd.html. Last accessed December 12, 2019.

138. Jones W, Klin A. Attention to eyes is present but in decline in2–6-month-old infants later diagnosed with autism. Nature. 2013;504(7480):427-431.

139. Sarrett JC, Rommelfanger KS. Commentary: Attention to eyes is present but in decline in2–6-month-old infants later diagnosed with autism. Front Public Health. 2015;3:272.

140. DeFilippis M, Wagner KD. Treatment of autism spectrum disorder in children and adolescents. Psychopharmacol Bull. 2016;46(2): 18-41.

141. Geier DA, Geier MR. An assessment of downward trends in neurodevelopmental disorders in the United States following removal of thimerosal from childhood vaccines. Med Sci Monit. 2006;12(6):CR231-CR239.

142. Kratz SV, Kerr J, Porter L. The use of craniosacral therapy for autism spectrum disorders: benefits from the viewpoints of parents, clients, and therapists. J Bodyw Mov Ther. 2017;21(1):19-29.

143. Geretsegger M, Elefant C, Mössler KA, Gold C. Music therapy for people with autism spectrum disorder. Cochrane Database Syst Rev. 2014;(6):CD004381.

Evidence-Based Practice Recommendations Citations

1. Schaefer GB, Mendelsohn NJ, Professional Practice and Guidelines Committee. Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions. Genet Med. 2013;15(5):399-407. Available at https://www.acmg.net/PDFLibrary/Austism-Spectrum-Genetics-Evaluation.pdf. Last accessed December 12, 2019.

2. Volkmar F, Siegel M, Woodbury-Smith M, et al. Practice parameter for the assessment and treatment of children and adolescents with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry. 2014;53(2):237-257. Available at https://www.jaacap.org/article/S0890-8567(13)00819-8/pdf. Last accessed December 12, 2019.

3. Scottish Intercollegiate Guidelines Network. Assessment, Diagnosis and Clinical Interventions for Children and Young People with Autism Spectrum Disorders: A National Clinical Guideline. Edinburgh: Scottish Intercollegiate Guidelines Network; 2016. Available at https://www.sign.ac.uk/assets/sign145.pdf. Last accessed December 12, 2019.


Copyright © 2017 NetCE, P.O. Box 997571, Sacramento, CA 95899-7571
Mention of commercial products does not indicate endorsement.